The Clinical Implications Of Cognitive Impairment and Allostatic Load in Bipolar Disorder
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Background: Allostatic load (AL) relates to the neural and bodily “wear and tear” that emerge in the context of chronic stress. This paper aims to provide clinicians with a comprehensive overview of the role of AL in patophysiology of bipolar disorder (BD) and its practical implications. Methods: PubMed searches were conducted on English-language articles published from 1970 to June 2011 using the search terms allostatic load, oxidative stress, staging, and bipolar disorder cross-referenced with cognitive impairment, comorbidity, mediators, prevention. Results: Progressive neural and physical dysfunction consequent to mood episodes in BD can be construed as a cumulative state of AL. The concept of AL can help to reconcile cognitive impairment and increased rates of clinical comorbidities that occur over the course of cumulative BD episodes. Conclusions: Data on transduction of psychosocial stress into the neurobiology of mood episodes converges to the concept of AL. Mood episodes prevention would not only alleviate emotional suffering, but also arrest the cycle of AL, cognitive decline, physical morbidities and, eventually, related mortality. These objectives can be achieved by focusing on effective prophylaxis from the first stages of the disorder, providing mood-stabilizing agents and standardized psychoeducation and, potentially, addressing cognitive deficits by the means of specific medication and neuropsychological interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 1×
“can be considered as neurobiological markers implicated in neurodegeneration and cognitive impairment in BD [37,65].”
BackgroundThe concept of allostasis in biology and biomedicine
McEwen, B. S., & Wingfield, J. C. (2003) · Hormones and Behavior · doi:10.1016/s0018-506x(02)00024-7 · Cited by 3,302 · cited 1×
“challenges [87].”
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Allostatic load biomarkers of chronic stress and impact on health and cognition
Juster, R.-P., McEwen, B. S., & Lupien, S. J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.10.002 · Cited by 2,565 · cited 1×
“AL can have important biomedical implications [52].”
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.8.999 · Cited by 1,848 · cited 1×
“In the early 1990s, Post has put forward the ‘‘kindling theory’’ according to which biochemical and anatomical substrates underlying the affective disorders evolve over time as a function of recurrences, favouring new episodes on one hand and reducing pharmacological responsivity on the other [112].”
BackgroundVyas, A., Mitra, R., Shankaranarayana Rao, B. S., & Chattarji, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06810.2002 · Cited by 1,662 · cited 1×
“glial cells [34], and amygdala [165,164].”
MCEWEN, B. S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1314.001 · Cited by 1,638
Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging
Seeman, T. E., McEwen, B. S., Rowe, J. W., & Singer, B. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081072698 · Cited by 1,385 · cited 1×
“007 and all-cause mortality in cross-sectional and follow-up studies [57,56,58,135,134,133].”
BackgroundSeeman, T. E. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440400111013 · Cited by 1,368
Cited by
Lopresti, A. L., & Drummond, P. D. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.05.005 · Cited by 231
Kapczinski, F., Magalhães, P. V. S., Balanzá‐Martinez, V., Dias, V. V., Frangou, S., Gama, C. S., Gonzalez‐Pinto, A., Grande, I., Ha, K., Kauer‐Sant'Anna, M., et al. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12305 · Cited by 217
“More severe neurocognitive deficits are not only associated with illness severity (47, 48), but also associated with cumulative mood episodes (49, 50).”
BackgroundSelf-citationAreas of controversy in neuroprogression in bipolar disorder
Passos, I. C., Mwangi, B., Vieta, E., Berk, M., & Kapczinski, F. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12581 · Cited by 208
“However, not all patients with BD will present these unfavorable clinical features, either as a consequence of treatment or baseline clinical characteristics (12).”
BackgroundSelf-citationVieta, E., Reinares, M., & Rosa, A. R. (2011) · Neurotoxicity Research · doi:10.1007/s12640-010-9197-8 · Cited by 120
Self-citationBalmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103
“[150] suggested that alongside the progression of the BD, several markers such as neurotrophins and inflammatory cytokines (tumor necrosis factor-alpha (TNFa)) could be well correlated to the pathological evolution of the disorder.”
BackgroundBonnín, C. D. M., González-Pinto, A., Solé, B., Reinares, M., González-Ortega, I., Alberich, S., Crespo, J. M., Salamero, M., Vieta, E., Martínez-Arán, A., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.034 · Cited by 76
“) that might have also exerted some effects on functional impairment (Vieta et al., 2013; Kapczinski et al., 2008; Soeiro-de-Souza et al., 2013; Grande et al., 2013).”
BackgroundSelf-citationNeurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder
Pfaffenseller, B., Fries, G. R., Wollenhaupt-Aguiar, B., Colpo, G. D., Stertz, L., Panizzutti, B., Magalhães, P. V., & Kapczinski, F. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811981 · Cited by 68
Self-citationSerafini, G., Pardini, M., Monacelli, F., Orso, B., Girtler, N., Brugnolo, A., Amore, M., Nobili, F., & Team on Dementia of the IRCCS Ospedale Policlinico San Martino (2021) · Brain Sciences · doi:10.3390/brainsci11020276 · Cited by 56
Popovic, D., Vieta, E., Fornaro, M., & Perugi, G. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.008 · Cited by 51
“Cognitive impairment, in fact, may be considered a measure of allostatic load (Vieta et al., 2013).”
BackgroundSelf-citationBeyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology
Data-Franco, J., Singh, A., Popovic, D., Ashton, M., Berk, M., Vieta, E., Figueira, M. L., & Dean, O. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.09.004 · Cited by 38
Self-citationMikoteit, T., Hemmeter, U., Eckert, A., Brand, S., Bischof, R., Delini-Stula, A., Holsboer-Trachsler, E., & Beck, J. (2015) · Neuropsychobiology · doi:10.1159/000437439 · Cited by 25
Metadata
- Authors
- Vieta, E., Popovic, D., Rosa, A. R., Solé, B., Grande, I., Frey, B. N., Martinez-Aran, A., Sanchez-Moreno, J., Balanzá-Martínez, V., Tabarés-Seisdedos, R., & Kapczinski, F.
- Venue
- European Psychiatry
- Publisher
- Cambridge University Press (CUP)
- Published
- 2012-04-24
- Volume
- 28
- Issue
- 1
- Pages
- 21-29
- ISSN
- 0924-9338 (ISSN-L)
- 1778-3585
- OpenAlex
- W2136788180
- Cited by
- 147
- References
- 44
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.